Unlearn

Unlearn’s scientists believe that it will be possible to use deep learning models to build quan­ti­ta­tive, predictive models of all major biological phenomena. Along the way to solving that problem, Unlearn is working with pharma partners to build AI-driven digital twins of patients. It uses these twins to design more efficient and reliable clinical trials for specific indications.